798 related articles for article (PubMed ID: 25226008)
1. Anti-aging proof of concept study: results and summary.
Bruce S; Karnik J; Dryer L; Burkholder D
J Drugs Dermatol; 2014 Sep; 13(9):1074-81. PubMed ID: 25226008
[TBL] [Abstract][Full Text] [Related]
2. An evaluation of the effect of a topical product containing salicin on the visible signs of human skin aging.
Gopaul R; Knaggs HE; Lephart JF; Holley KC; Gibson EM
J Cosmet Dermatol; 2010 Sep; 9(3):196-201. PubMed ID: 20883292
[TBL] [Abstract][Full Text] [Related]
3. An open-label, single-site study to evaluate the tolerability, safety, and efficacy of using a novel facial moisturizer for preparation and accelerated healing pre and post a single full-face radiofrequency microneedling treatment.
Zahr AS; Kononov T; Sensing W; Biron JA; Gold MH
J Cosmet Dermatol; 2019 Feb; 18(1):94-106. PubMed ID: 30456804
[TBL] [Abstract][Full Text] [Related]
4. An evaluation of the effect of a topical product containing C-xyloside and blueberry extract on the appearance of type II diabetic skin.
Draelos ZD; Yatskayer M; Raab S; Oresajo C
J Cosmet Dermatol; 2009 Jun; 8(2):147-51. PubMed ID: 19527341
[TBL] [Abstract][Full Text] [Related]
5. The Anti-Aging Effects of Low Oxygen Tension Generated Multipotent Growth Factor Containing Serum.
Draelos ZD; Karnik J; Naughton G
J Drugs Dermatol; 2017 Jan; 16(1):30-34. PubMed ID: 28095530
[TBL] [Abstract][Full Text] [Related]
6. Safety and efficacy of two anti-acne/anti-aging treatments in subjects with photodamaged skin and mild to moderate acne vulgaris.
Kircik LH; Dahl A; Yatskayer M; Raab S; Oresajo C
J Drugs Dermatol; 2012 Jun; 11(6):737-40. PubMed ID: 22648221
[TBL] [Abstract][Full Text] [Related]
7. An Open Label Clinical Trial of a Multi-Ingredient Anti-Aging Moisturizer Designed to Improve the Appearance of Facial Skin.
Herndon JH; Jiang L; Kononov T; Fox T
J Drugs Dermatol; 2015 Jul; 14(7):699-704. PubMed ID: 26151786
[TBL] [Abstract][Full Text] [Related]
8. Application of a topical biomimetic electrical signaling technology to photo-aging: a randomized, double-blind, placebo-controlled trial of a galvanic zinc-copper complex.
Chantalat J; Bruning E; Sun Y; Liu JC
J Drugs Dermatol; 2012 Jan; 11(1):30-7. PubMed ID: 22206074
[TBL] [Abstract][Full Text] [Related]
9. Minimally ablative resurfacing with the confluent 2,790 nm erbium:YSGG laser: a pilot study on safety and efficacy.
Walgrave SE; Kist DA; Noyaner-Turley A; Zelickson BD
Lasers Surg Med; 2012 Feb; 44(2):103-11. PubMed ID: 22302749
[TBL] [Abstract][Full Text] [Related]
10. The Effect of a Combination of Recombinant EGF Cosmetic Serum and a Crosslinked Hyaluronic Acid Serum as Compared to a Fibroblast-Conditioned Media Serum on the Appearance of Aging Skin.
Draelos ZD
J Drugs Dermatol; 2016 Jun; 15(6):738-41. PubMed ID: 27272082
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of a novel anti-aging topical formulation containing cycloastragenol, growth factors, peptides, and antioxidants.
Weiss RA; Weiss MA
J Drugs Dermatol; 2014 Sep; 13(9):1135-9. PubMed ID: 25226016
[TBL] [Abstract][Full Text] [Related]
12. Brightening and Improvement of Facial Skin Quality in Healthy Female Subjects With Moderate Hyperpigmentation or Dark Spots and Moderate Facial Aging.
Serra M; Bohnert K; Narda M; Granger C; Sadick N
J Drugs Dermatol; 2018 Dec; 17(12):1310-1315. PubMed ID: 30586263
[TBL] [Abstract][Full Text] [Related]
13. An Open Label Clinical Trial of a Peptide Treatment Serum and Supporting Regimen Designed to Improve the Appearance of Aging Facial Skin.
Draelos ZD; Kononov T; Fox T
J Drugs Dermatol; 2016 Sep; 15(9):1100-6. PubMed ID: 27602972
[TBL] [Abstract][Full Text] [Related]
14. A novel, volumizing cosmetic formulation significantly improves the appearance of target Glabellar lines, nasolabial folds, and crow's feet in a double-blind, vehicle-controlled clinical trial.
Farris PK; Edison BL; Weinkauf RL; Green BA
J Drugs Dermatol; 2014 Jan; 13(1):41-6. PubMed ID: 24385118
[TBL] [Abstract][Full Text] [Related]
15. Combination of physiologically balanced growth factors with antioxidants for reversal of facial photodamage.
Atkin DH; Trookman NS; Rizer RL; Schreck LE; Ho ET; Gotz V; Ford RO; Mehta RC
J Cosmet Laser Ther; 2010 Feb; 12(1):14-20. PubMed ID: 20085451
[TBL] [Abstract][Full Text] [Related]
16. Multi-Center, Double-Blind, Vehicle-Controlled Clinical Trial of an Alpha and Beta Defensin-Containing Anti-Aging Skin Care Regimen With Clinical, Histopathologic, Immunohistochemical, Photographic, and Ultrasound Evaluation.
Taub A; Bucay V; Keller G; Williams J; Mehregan D
J Drugs Dermatol; 2018 Apr; 17(4):426-441. PubMed ID: 29601620
[TBL] [Abstract][Full Text] [Related]
17. A randomized, double-blind, controlled comparative trial of the anti-aging properties of non-prescription tri-retinol 1.1% vs. prescription tretinoin 0.025%.
Ho ET; Trookman NS; Sperber BR; Rizer RL; Spindler R; Sonti S; Gotz V; Mehta R
J Drugs Dermatol; 2012 Jan; 11(1):64-9. PubMed ID: 22206079
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and Tolerability of a Novel Topical Treatment for Neck: A Randomized, Double-blind, Regimen-Controlled Study.
Makino ET; Kadoya K; Chung R; Jiang L; Mikati M; Mehta RC
J Drugs Dermatol; 2021 Feb; 20(2):184-191. PubMed ID: 33538566
[TBL] [Abstract][Full Text] [Related]
19. A Double-Blind, 12-Week Study to Evaluate the Antiaging Efficacy of a Cream Containing the NFκB Inhibitor 4-Hexyl-1, 3-Phenylenediol and Ascorbic Acid-2 Glucoside in Adult Females.
Roure R; Nollent V; Dayan L; Camel E; Bertin C
J Drugs Dermatol; 2016 Jun; 15(6):750-8. PubMed ID: 27272084
[TBL] [Abstract][Full Text] [Related]
20. Safety and efficacy evaluation of tretinoin cream 0.02% for the reduction of photodamage: a pilot study.
Kircik LH
J Drugs Dermatol; 2012 Jan; 11(1):83-90. PubMed ID: 22206082
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
